
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In vivo synthetic chemistry of proteolysis targeting chimeras (PROTACs)
Shusuke Tomoshige, Minoru Ishikawa
Bioorganic & Medicinal Chemistry (2021) Vol. 41, pp. 116221-116221
Closed Access | Times Cited: 10
Shusuke Tomoshige, Minoru Ishikawa
Bioorganic & Medicinal Chemistry (2021) Vol. 41, pp. 116221-116221
Closed Access | Times Cited: 10
Showing 10 citing articles:
Strategies for designing proteolysis targeting chimaeras (PROTACs)
Shipeng He, Guoqiang Dong, Junfei Cheng, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1280-1342
Closed Access | Times Cited: 73
Shipeng He, Guoqiang Dong, Junfei Cheng, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1280-1342
Closed Access | Times Cited: 73
Novel strategies and promising opportunities for targeted protein degradation: An innovative therapeutic approach to overcome cancer resistance
Huanjie Zhu, Jin Wang, Qingqing Zhang, et al.
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108371-108371
Closed Access | Times Cited: 20
Huanjie Zhu, Jin Wang, Qingqing Zhang, et al.
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108371-108371
Closed Access | Times Cited: 20
MDM2-Based Proteolysis-Targeting Chimeras (PROTACs): An Innovative Drug Strategy for Cancer Treatment
André T. S. Vicente, Jorge A. R. Salvador
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11068-11068
Open Access | Times Cited: 26
André T. S. Vicente, Jorge A. R. Salvador
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11068-11068
Open Access | Times Cited: 26
Click Chemistry and Targeted Degradation: A Winning Combination for Medicinal Chemists?
Anna Pasieka, Eleonora Diamanti, Elisa Uliassi, et al.
ChemMedChem (2023) Vol. 18, Iss. 20
Open Access | Times Cited: 14
Anna Pasieka, Eleonora Diamanti, Elisa Uliassi, et al.
ChemMedChem (2023) Vol. 18, Iss. 20
Open Access | Times Cited: 14
Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction
Ru Si, Ping Hai, Yongbiao Zheng, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115497-115497
Closed Access | Times Cited: 13
Ru Si, Ping Hai, Yongbiao Zheng, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115497-115497
Closed Access | Times Cited: 13
Targeted protein degradation might present a novel therapeutic approach in the fight against African trypanosomiasis
Ammar Usman Danazumi, Ibtida Tabassum Ishmam, Salisu Idris, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 186, pp. 106451-106451
Open Access | Times Cited: 7
Ammar Usman Danazumi, Ibtida Tabassum Ishmam, Salisu Idris, et al.
European Journal of Pharmaceutical Sciences (2023) Vol. 186, pp. 106451-106451
Open Access | Times Cited: 7
Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (PROTAC)
Constanza Salinas-Rebolledo, Javier Blesa, G Valenzuela, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Constanza Salinas-Rebolledo, Javier Blesa, G Valenzuela, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Reversible in-situ assembly of PROTACs using iminoboronate conjugation
Ce Yang, Yayun Xie, Xiaoxiao Yang, et al.
Research Square (Research Square) (2024)
Open Access
Ce Yang, Yayun Xie, Xiaoxiao Yang, et al.
Research Square (Research Square) (2024)
Open Access
Reversible in-situ assembly of PROTACs using iminoboronate conjugation
Ce Yang, Yayun Xie, Xiaoxiao Yang, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 8, pp. 1432-1439
Open Access
Ce Yang, Yayun Xie, Xiaoxiao Yang, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 8, pp. 1432-1439
Open Access
WITHDRAWN: Targeted protein degradation: A promising approach for cancer treatment
Muhammad Zafar Irshad Khan, Adila Nazli, Iffat Naz, et al.
Journal of Pharmaceutical Analysis (2023)
Open Access | Times Cited: 1
Muhammad Zafar Irshad Khan, Adila Nazli, Iffat Naz, et al.
Journal of Pharmaceutical Analysis (2023)
Open Access | Times Cited: 1